Back to GetFilings.com



Table of Contents

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 


 

 

x   Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

 

For the quarterly period ended March 31, 2003

 

or

 

¨   Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from              to             

 

Commission file number: 0-24260

 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

11-3131700

(State or Other Jurisdiction of

 

(I.R.S. Employer Identification No.)

Incorporation or Organization)

   

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes    þ     No    ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes    ¨     No    þ

 

Number of shares of Common Stock outstanding as of May 8, 2003: 9,456,382 shares

 



Table of Contents

 

PART I.

 

FINANCIAL INFORMATION

 

Item 1.

 

Financial Statements

  

3

   

Consolidated Balance Sheets as of March 31, 2003 and December 31, 2002

  

3

   

Consolidated Statements of Operations for the Three Months Ended March 31, 2003 and 2002

  

4

   

Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2003 and 2002

  

5

   

Notes to Consolidated Financial Statements

  

6

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

14

Item 3.

 

Quantitative and Qualitative Disclosures about Market Risks

  

19

Item 4.

 

Controls and Procedures

  

19

   

PART II.

    
   

OTHER INFORMATION

    

Item 1.

 

Legal Proceedings

  

20

Item 2.

 

Changes in Securities

  

20

Item 3.

 

Defaults Upon Senior Securities

  

20

Item 4.

 

Submission of Matters to a Vote of Security Holders

  

20

Item 5.

 

Other Information

  

20

Item 6.

 

Exhibits and Reports on Form 8-K

  

20

 

2


Table of Contents

Item 1. FINANCIAL STATEMENTS

 

AMEDISYS, INC. AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

 

As of March 31, 2003 and December 31, 2002

(Dollar amounts in 000’s)

 

    

March 31, 2003


      

December 31, 2002


 
    

(unaudited)

          

ASSETS:

                   

CURRENT ASSETS:

                   

Cash and cash equivalents

  

$

8,341

 

    

$

4,861

 

Patient accounts receivable, net of allowance for doubtful accounts of $2,309 in March 2003 and $1,865 in December 2002

  

 

10,227

 

    

 

13,467

 

Prepaid expenses

  

 

1,929

 

    

 

1,600

 

Deferred income taxes

  

 

2,080

 

    

 

1,803

 

Inventory and other current assets

  

 

1,092

 

    

 

857

 

    


    


Total current assets

  

 

23,669

 

    

 

22,588

 

Property and equipment, net

  

 

7,815

 

    

 

8,257

 

Deferred income taxes

  

 

774

 

    

 

1,711

 

Other assets, net

  

 

25,748

 

    

 

25,768

 

    


    


Total assets

  

$

58,006

 

    

$

58,324

 

    


    


LIABILITIES AND STOCKHOLDERS’ EQUITY:

                   

CURRENT LIABILITIES:

                   

Accounts payable

  

$

1,776

 

    

$

2,495

 

Accrued expenses:

                   

Payroll and payroll taxes

  

 

6,437

 

    

 

6,504

 

Insurance

  

 

2,112

 

    

 

2,171

 

Income taxes

  

 

458

 

    

 

297

 

Legal settlements

  

 

2,181

 

    

 

1,887

 

Other

  

 

2,435

 

    

 

2,439

 

Current portion of long-term debt

  

 

3,970

 

    

 

3,903

 

Current portion of obligations under capital leases

  

 

2,561

 

    

 

2,476

 

Current portion of Medicare liabilities

  

 

8,617

 

    

 

8,948

 

    


    


Total current liabilities

  

 

30,547

 

    

 

31,120

 

Long-term debt

  

 

3,674

 

    

 

4,474

 

Obligations under capital leases

  

 

534

 

    

 

1,042

 

Long-term Medicare liabilities

  

 

3,328

 

    

 

3,898

 

Other long-term liabilities

  

 

826

 

    

 

827

 

    


    


Total liabilities

  

 

38,909

 

    

 

41,361

 

STOCKHOLDER’S EQUITY:

                   

Preferred stock, .001 par value, 5,000,000 shares authorized; none outstanding

  

 

—  

 

    

 

—  

 

Common stock .001 par value, 30,000,000 shares authorized; (9,411,725 and 9,167,976 shares issued at March 31, 2003 and December 31, 2002, respectively)

  

 

9

 

    

 

9

 

Additional paid-in capital

  

 

30,424

 

    

 

29,439

 

Treasury stock at cost (4,167 shares of common stock held at March 31, 2003 and December 31, 2002)

  

 

(25

)

    

 

(25

)

Retained earnings (deficit)

  

 

(11,311

)

    

 

(12,460

)

    


    


Total stockholder’s equity

  

 

19,097

 

    

 

16,963

 

    


    


Total liabilities and stockholder’s equity

  

$

58,006

 

    

$

58,324

 

    


    


 

The accompanying notes are an integral part of these consolidated financial statements.

 

3


Table of Contents

AMEDISYS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF OPERATIONS

For the three months ended March 31, 2003 and 2002

(Unaudited, Dollar amounts in 000’s, except per share data)

 

    

Three months ended


 
    

March 31, 2003


    

March 31, 2002


 

Net service revenue

  

$

31,132

 

  

$

31,850

 

Cost of service revenue

  

 

12,909

 

  

 

13,869

 

    


  


Gross margin

  

 

18,223

 

  

 

17,981

 

    


  


General and administrative expenses:

                 

Salaries and benefits

  

 

9,861

 

  

 

9,431

 

Other

  

 

6,178

 

  

 

5,557

 

    


  


Total general and administrative expenses

  

 

16,039

 

  

 

14,988

 

    


  


Operating income

  

 

2,184

 

  

 

2,993

 

    


  


Other income and expense:

                 

Interest income

  

 

17

 

  

 

18

 

Interest expense

  

 

(360

)

  

 

(578

)

Other income, net

  

 

10

 

  

 

131

 

    


  


Total other expense, net

  

 

(333

)

  

 

(429

)

    


  


Income before income taxes

  

 

1,851

 

  

 

2,564

 

Income tax expense (benefit)

  

 

702

 

  

 

(1,438

)

    


  


Net income

  

$

1,149

 

  

$

4,002

 

    


  


Basic weighted average common shares outstanding

  

 

9,327,000

 

  

 

7,241,000

 

Basic net income per common share

  

$

0.12

 

  

$

0.55

 

    


  


Diluted weighted average common shares outstanding

  

 

9,501,000

 

  

 

7,768,000

 

Diluted net income per common share

  

$

0.12

 

  

$

0.52

 

    


  


 

The accompanying notes are an integral part of these consolidated financial statements.

 

4


Table of Contents

AMEDISYS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended March 31, 2003 and 2002

(Unaudited, Dollar amounts in 000’s)

 

      

Three months ended


 
      

March 31, 2003


      

March 31, 2002


 

CASH FLOWS FROM OPERATING ACTIVITIES:

                     

Net Income

    

$

1,149

 

    

$

4,002

 

Adjustments to reconcile net income to net cash provided by operating activities:

                     

Depreciation and amortization

    

 

740

 

    

 

773

 

Provision for bad debts

    

 

494

 

    

 

679

 

Deferred income taxes

    

 

660

 

    

 

(1,519

)

Tax benefit from stock option exercises

    

 

9

 

    

 

—  

 

Changes in assets and liabilities:

                     

Decrease in accounts receivable

    

 

2,746

 

    

 

4,489

 

(Increase) in inventory and other current assets

    

 

(564

)

    

 

(1,242

)

Decrease (increase) in other assets

    

 

20

 

    

 

(51

)

(Decrease) in accounts payable

    

 

(719

)

    

 

(59

)

Increase (decrease) in accrued expenses

    

 

848

 

    

 

(294

)

      


    


Net cash provided by operating activities

    

 

5,383